Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder

By Shariat S.F.   Kim J.   Raptidis G.   Ayala G.E.   Lerner S.P.  

Urology, Vol. 61, Iss. 6, 2003-06 ,pp. : 1140-1145

Elsevier

Access to resources Recommend Favorite

Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma

By Visapaa H.   Bui M.   Huang Y.   Seligson D.   Tsai H.   Pantuck A.   Figlin R.   Rao J.Y.u.   Belldegrun A.   Horvath S.   Palotie A.  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 845-850

Elsevier

Access to resources Recommend Favorite

Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma

By Rioux-Leclercq N.   Turlin B.   Bansard J.-Y.   Patard J.-J.   Manunta A.   Moulinoux J.-P.   Guille F.   Ramee M.-P.   Lobel B.  

Urology, Vol. 55, Iss. 4, 2000-04 ,pp. : 501-505

Elsevier

Access to resources Recommend Favorite

p53, bcl-2, and Bax Expression in Renal Cell Carcinoma - immunohistochemical detection of p53 protein versus clinicopathologic parameters

By Vasavada S.P.   Novick A.C.   Williams B.R.G.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 1057-1061

Elsevier

Access to resources Recommend Favorite

Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma

By Uchida T.   Gao J.-P.   Wang C.   Jiang S.-X.   Muramoto M.   Satoh T.   Minei S.   Shimura S.   Irie A.   Kameya T.   Baba S.  

Urology, Vol. 59, Iss. 4, 2002-04 ,pp. : 615-620

Elsevier

Access to resources Recommend Favorite